Travere Therapeutics's total assets for Q4 2024 were $594.13M, an increase of 17.79% from the previous quarter. TVTX total liabilities were $535.05M for the fiscal quarter, a 0.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.